alpha b-crystallin
Recombinant proteinexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2009 (NCT02442557)
Timeline
Indications
Studied for
Mechanism of action
- Nucleoredoxin-like protein 2MODULATOR
NXNL2 modulator
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- alpha b-crystallin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02442570 | Phase 2 | Sep 1, 2012 | Delta Crystallon BV, PSI CRO |
| NCT02442557 | Phase 1 | Dec 1, 2009 | Delta Crystallon BV, INC Research |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Delta Crystallon BV | For profit | 2 | 2 | 2 | 2009 |
| INC Research | For profit | 1 | 0 | 1 | 2009 |
| PSI CRO | For profit | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1